Researchers from Swinburne University received funding to continue investigating the links found between adhering to the Mediterranean diet and a reduced risk of dementia.
Australian researchers have been awarded about 1.8 million Australian dollars ($1.2 million) in funding by the country’s National Health Medical Research Council (NHMRC), enabling them to continue with an ongoing study into the effectiveness of the Mediterranean diet and exercise in preventing the onset of dementia.
The Swinburne University-based clinical trial, which will be led by Andrew Pipingas, will investigate the underlying reasons behind why adhering to a MedDiet and regular exercise program could reduce cognitive decline and become an effective tool for warding off dementia.
As it’s extremely difficult to find a cure and treat those in the later stages of the disease, focusing our efforts on helping those at risk of developing dementia to stay healthy is one way to ensure Australians stay well in future.- Andrew Pipingas, researcher at Swinburne University
Pipingas believes the research could provide answers on how to help the elderly stay healthy and enjoy a good quality of life.
“As it’s extremely difficult to find a cure and treat those in the later stages of the disease, focusing our efforts on helping those at risk of developing dementia to stay healthy is one way to ensure Australians stay well in future,” he said in a press release.
See Also:Health NewsThe team will also evaluate the cost-effectiveness of the intervention, which is expected to reduce both the social and economic burdens associated with dementia care in a growing elderly population.
“We’re looking at potentially saving billions of dollars for the health industry,” Pipingas said. “The issue of dementia is going to continue to be a huge deal as we face an aging population, with up to AUD$1 trillion ($690 billion) being spent on treating dementia over the next 40 years.”
The funding will enable Swinburne and its Australian and international partnering institutions to expand on an earlier study, which focused on how a Mediterranean diet affected the brain over time.
This study revealed that adhering to a Mediterranean diet improved cognition, slowed cognitive decline and could potentially prevent the development of Alzheimer’s disease.
Lead author Roy Hardman analyzed the results of 135 studies on the positive effects of a MedDiet and discovered that the benefits were not limited to participants living in the Mediterranean region, but were also enjoyed by residents of various countries around the world.
Hardman concluded that a Mediterranean diet, which is rich in leafy greens, fresh fruit and vegetables, cereals, beans, seeds, nuts, and legumes, with olive oil as its primary source of fat, resulted in better attention, memory and language. Particularly positive effects on memory included delayed recognition, long-term and working memory, executive function and visual constructs.
It was found that when olive oil was the main source of dietary fat, lipid profiles were changed which could assist in maintaining a healthy weight and potentially reduce obesity. Olive oil was also attributed with improving polyphenols in the blood and boosting cellular energy metabolism.
Hardman linked the MedDiet with its limited amounts of red meat and dairy produce with reducing some of the modifiable risk factors. These included increasing micronutrients and improving vitamin and mineral imbalances.
The next phase of the study will examine the cognitive effects of the MedDiet on more than 100 Australians aged between 60 and 90 who live independently within care facilities for the elderly and are considered to be mentally healthy and the AUD$1,772,616 ($1,228,201) grant will be distributed over four years.
The Swinburne team will be supported by the University of South Australia, La Trobe University, Deakin University, Murdoch University, Sheffield Hallam University and University of East Anglia.
In 2017, researchers from the University of Louisiana-Monroe discovered that oleocanthal, a compound found in extra virgin olive oil, was effective in preventing Alzheimer’s disease in mice and and held the potential to become an effective dietary supplement for warding off dementia.
More articles on: Alzheimer's, Australia, health
Apr. 9, 2024
The Role of Monounsaturated Fatty Acids in Olive Oil's Health Benefits
Oleic acid, classified as a monounsaturated fatty acid (MUFA), has been extensively studied by scientists over the last decades, consistently demonstrating many positive effects on human health.
May. 23, 2024
First OlivitalyMed Festival Hailed as Success in Cilento
The event, which spotlighted extra virgin olive oil in Campania and Italy, also hosted conferences on cooking, health, tourism and science.
Feb. 1, 2024
Olive Oil Metabolites Linked with Improved Cardiovascular Disease Outcomes
The research demonstrated a link between virgin olive oil metabolite profiles and reduced risk of cardiovascular disease, but not diabetes.
Oct. 31, 2024
Study Suggests Stink Bug Caused Mysterious Fruit Drop in Italy
The brown marmorated stink bug has been identified in Italian and Greek olive groves. Increasing evidence now links its presence to an early fruit drop in northern Italy.
Nov. 13, 2024
Early Intervention with EVOO Shows Promise in Reducing Down Syndrome Symptoms
New research in mice suggests that extra virgin olive oil consumption could mitigate neurodegenerative effects caused by Downs syndrome.
Jan. 2, 2024
Study Reveals How Polyphenols Lower Insulin Resistance
Mice fed a high-fat diet comprised of polyphenol-enriched extra virgin olive oil demonstrated gene expressions associated with reduced oxidative stress and inflammation.
Oct. 18, 2024
Small Study Suggests Anti-Aging Potential of Polyphenols on Skin
Oleocanthal and oleacein significantly reduced wrinkle count in both men and women.
Mar. 21, 2024
Study Questions the Accuracy of Olive Tree Dating Methods
Using radiocarbon dating, researchers concluded a 1,100-year-old tree in Lebanon is the world’s oldest olive tree. Other experts believe the method may have been flawed.